E-nside TAAA MultiBranch Stent Graft System - Graft, vascular, synthetic
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
22-10-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Cryolife Medical (Australia) Company Pty Ltd
Class:
Class III
Manufactured by:
Jotec GmbH Lotzenacker 23, Hechingen, 72379 Germany
Therapeutic area:
35281 - Graft, vascular, synthetic
Therapeutic indications:
The E-nside stent graft is delivered sterile, loaded in a delivery system. It is a self-expanding stent graft remaining in the body after deployment. The implant is available in various sizes which differ in their proximal and distal diameters. The E-nside TAAA Multibranch Stent Graft System is indicated for endovascular treatments of patients with thoracoabdominal aortic aneurysms.
Authorization status:
A
Authorization date:
2021-09-08
